OpenVSafe by OpenVAERS
Search V-safe

YU3-60996-11461

2 vaccinations 6 coded responses 7 check-ins 6 free-text entries 6 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
773 / TX
Registered
2021-08-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-07-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-08-13
    Registered in v-safe
  3. 2021-08-15
    Survey response — day 21, dose 1
    MedDRA: Cerebrovascular accident, Head discomfort, Papilloedema — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    Free text: Stroke Intracranial pressure Papilledema
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  4. 2021-08-15
    Report sent to call center — day 21, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  5. 2021-08-20
    Survey response — day 28, dose 1
    MedDRA: Cerebrovascular accident, Headache, Intracranial pressure increased, Menstruation irregular, Muscular weakness, Nausea, Papilloedema — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    Free text: Stroke , intracranial pressure ; papilledema; missed menstrual cycle. Headaches , nausea, right limb weakness
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  6. 2021-08-20
    Report sent to call center — day 28, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  7. 2021-08-23
  8. 2021-08-25
  9. 2021-08-27
    Survey response — day 35, dose 1
    MedDRA: Papilloedema, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Lumbar puncture for papilledema
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  10. 2021-08-27
    Report sent to call center — day 35, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  11. 2021-08-31
  12. 2021-09-01
  13. 2021-09-30
    Dose 2 — Pfizer-BioNTech
  14. 2021-10-22
    Survey response — 3 months, dose 1
    MedDRA: Cardiac disorder, Idiopathic intracranial hypertension — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Pseudo tumor cerebri , heart condition
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-10-22
    Report sent to call center — 3 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  16. 2021-10-27
  17. 2021-11-01
  18. 2022-01-21
    Survey response — 6 months, dose 1
    MedDRA: Alopecia, Arthralgia, Dizziness, Fatigue, Goitre, Headache, Hepatomegaly, Lymphadenopathy, Myalgia, Oxygen saturation decreased, Palpitations — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    Free text: Heart palpitations Hair loss Enlarged lymph nodes Enlarged liver Low blood oxygen Headaches Fatigue Dizziness Muscle pain Joint pain Enlarged thyroid gland
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-01-21
    Report sent to call center — 6 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  20. 2022-01-24
  21. 2022-01-27
  22. 2022-03-31
    Survey response — 6 months, dose 2
    MedDRA: Asthenia, Burning sensation, Depression, Irritability, Lymphadenopathy, Skin burning sensation — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Burning sensation on face, arms, legs . Irritability, depression, enlarged lymph nodes, weakness
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-03-31
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  24. 2022-04-04
  25. 2022-09-30
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-07-23Pfizer-BioNTech No
22021-09-30Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-08-15 Unsuccessful Reported to VAERS voluntarily prior to GDIT contact
2021-08-20 Unsuccessful Reported to VAERS voluntarily prior to GDIT contact
2021-08-27 Unsuccessful Reported to VAERS voluntarily prior to GDIT contact
2021-10-22 Unsuccessful
2022-01-21 Unsuccessful
2022-03-31 Unsuccessful

Free text

Release 9 — day 21, dose 1

2021-08-15

Symptoms: Stroke Intracranial pressure Papilledema

Release 9 — day 28, dose 1

2021-08-20

Symptoms: Stroke , intracranial pressure ; papilledema; missed menstrual cycle. Headaches , nausea, right limb weakness

Release 9 — day 35, dose 1

2021-08-27

Symptoms: Lumbar puncture for papilledema

Release 10 — 3 months, dose 1

2021-10-22

Symptoms: Pseudo tumor cerebri , heart condition

Release 11 — 6 months, dose 1

2022-01-21

Symptoms: Heart palpitations Hair loss Enlarged lymph nodes Enlarged liver Low blood oxygen Headaches Fatigue Dizziness Muscle pain Joint pain Enlarged thyroid gland

Release 11 — 6 months, dose 2

2022-03-31

Symptoms: Burning sensation on face, arms, legs . Irritability, depression, enlarged lymph nodes, weakness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAlopecia · · ✓
SDArthralgia · · ✓
SDAsthenia · · ✓
SDBurning sensation · · ✓
SDCardiac disorder · · ✓
SDCerebrovascular accident ✓ · ✓
SDDepression · · ✓
SDDizziness · · ✓
SDFatigue · · ✓
SDGoitre · · ✓
SDHead discomfort ✓ · ✓
SDHeadache ✓ · ✓
SDHepatomegaly · · ✓
SDIdiopathic intracranial hypertension · · ✓
SDIntracranial pressure increased ✓ · ✓
SDIrritability · · ✓
SDLymphadenopathy · · ✓
SDMenstruation irregular ✓ · ✓
SDMuscular weakness ✓ · ✓
SDMyalgia · · ✓
SDNausea ✓ · ✓
SDOxygen saturation decreased · · ✓
SDPalpitations · · ✓
SDPapilloedema ✓ · ✓
SDSkin burning sensation · · ✓
SDUnevaluable event ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release